What is Biostrategy Analytics?
Biostrategy Analytics’s mission is to provide Pharma and Biotech companies with pragmatic analyses and deep insights into the industry.
Investment Associate – Big Pi Ventures
(Dec. 2018 – present)
Big Pi Ventures is a leading VC Fund in Greece focused on investing in deep technology start-ups. Dimitris is involved in evaluating early stage investment opportunities with focus on health-tech start-ups.
Corporate Development Mngr – Genesis Pharma
(Jun. 2015 – Jan. 2017)
Product portfolio expansion, biotech in-licensing deals, market access and reimbursement strategies.
Consultant – Deloitte
(Feb. 2013 – Dec. 2014)
Sell-side M&A mandates, building information memorandums, valuation models, buyers target list and company profiles.
Consultant – Novumed Life Sciences Consulting
(Jun. 2012 – Nov. 2012)
Performing market and deal analyses to enable Pharma clients’ optimize their investment decision making.
MSc Management of Biotech Companies
Grenoble Ecole de Management (2013)
MSc Social Sciences
London School of Economics (2012)
Imperial College London (2011)
BEng Chemical Engineering
University College London (UCL) (2009)